Farringdon Capital’s Humana HUM Stock Holding History

Farringdon Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-937	Closed	-$240K	–	478
2025 Q4	$240K	Buy	+937	New	+$246K	0.06%	361
2025 Q3	–	Sell	-1,384	Closed	-$338K	–	546
2025 Q2	$338K	Buy	+1,384	New	+$345K	0.11%	294

Other funds holding HUM

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Farringdon Capital's HUM Position: Q1 2026 in Review

Farringdon Capital sold out of Humana (HUM) in Q1 2026, closing a stake of 937 shares — an estimated $240K sold.

Farringdon Capital first reported a position in HUM in Q2 2025 and held it in 2 quarters. The position peaked at $338K in Q2 2025. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

Farringdon Capital reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
Farringdon Capital sold 937 Humana shares in Q1 2026, an estimated $240K.
Farringdon Capital first reported a position in Humana in Q2 2025 and held it in 2 quarters.
Farringdon Capital's Humana position peaked at $338K in Q2 2025.
779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.